Pediatric GNAO1 encephalopathies are characterized by a spectrum of clinical manifestations, including early-onset epilepsy, motor dysfunctions, developmental delay, intellectual disability, and occasional brain atrophy (4–7). The gene discussed is GNAO1; the disease is epilepsy.